Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

NICE (NICE) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for NICE (NICE) over the last 17 years, with Q3 2025 value amounting to $7380.0.

  • NICE's Shares Outstanding (Weighted Average) rose 3641.4% to $7380.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7380.0, marking a year-over-year increase of 3641.4%. This contributed to the annual value of $5050.0 for FY2025, which is 4428.57% up from last year.
  • Per NICE's latest filing, its Shares Outstanding (Weighted Average) stood at $7380.0 for Q3 2025, which was up 3641.4% from $5050.0 recorded in Q2 2025.
  • NICE's Shares Outstanding (Weighted Average)'s 5-year high stood at $63.8 million during Q4 2022, with a 5-year trough of $1200.0 in Q1 2023.
  • For the 5-year period, NICE's Shares Outstanding (Weighted Average) averaged around $13.4 million, with its median value being $4030.0 (2023).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 842500.0% in 2021, then crashed by 9811.72% in 2023.
  • Over the past 5 years, NICE's Shares Outstanding (Weighted Average) (Quarter) stood at $63.2 million in 2021, then rose by 0.95% to $63.8 million in 2022, then decreased by 0.31% to $63.6 million in 2023, then decreased by 0.17% to $63.5 million in 2024, then tumbled by 99.99% to $7380.0 in 2025.
  • Its Shares Outstanding (Weighted Average) was $7380.0 in Q3 2025, compared to $5050.0 in Q2 2025 and $2040.0 in Q1 2025.